Prevalence of acquired and transmitted HIV drug resistance in Iran: a systematic review and meta-analysis

被引:0
作者
Hossein Mirzaei
Sana Eybpoosh
Fatemeh Mehrabi
Mohammad Reza Shojaei
Ali Mirzazadeh
Mehrdad Khezri
Naser Nasiri
Hamid Sharifi
机构
[1] HIV/STI Surveillance Research Center,Department of Epidemiology and Biostatistics, Research Centre for Emerging and Reemerging Infectious Diseases
[2] and WHO Collaborating Center for HIV Surveillance,Department of Microbiology and Virology
[3] Institute for Futures Studies in Health,Department of Epidemiology and Biostatistics, Institute for Global Health Sciences
[4] Kerman University of Medical Sciences,Department of Epidemiology
[5] Pasteur Institute of Iran,School of Health
[6] Kerman University of Medical Science,Affiliate, Institute for Global Health Sciences
[7] University of California,undefined
[8] New York University School of Global Public Health,undefined
[9] Jiroft University of Medical Sciences,undefined
[10] University of California San Francisco,undefined
来源
BMC Infectious Diseases | / 24卷
关键词
Anti-retroviral agents; Drug resistance; Viral; HIV infections; Treatment failure;
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
相关论文
共 220 条
  • [1] Chung MH(2020)Evaluation of the management of pretreatment HIV drug resistance by oligonucleotide ligation assay: a randomised controlled trial The Lancet HIV 7 e104-e112
  • [2] McGrath CJ(2012)Effect of pretreatment HIV-1 drug resistance on immunological, virological, and drug-resistance outcomes of first-line antiretroviral treatment in sub-Saharan Africa: a multicentre cohort study Lancet Infect Dis 12 307-317
  • [3] Beck IA(2014)Metaprop: a Stata command to perform meta-analysis of binomial data Arch Public Health 72 1-10
  • [4] Levine M(2020)HIV-1 integrase drug-resistance mutations in Iranian treatment-experienced HIV-1-infected patients Arch Virol 165 115-125
  • [5] Milne RS(2020)HIV-1 reverse transcriptase and protease mutations for drug-resistance detection among treatment-experienced and naive HIV-infected individuals PLoS One 15 15-300
  • [6] So I(2019)Evaluation of acquired HIV drug resistance among people living with HIV who have taken antiretroviral therapy for 9–15 months in 14 triangular clinics in Iran, 2015–2016 Intervirology 61 292-79
  • [7] Hamers RL(2019)HIV-1 drug resistance mutations among antiretroviral drug-experienced patients in the South of Iran Intervirology 62 72-63
  • [8] Schuurman R(2019)HIV drug resistance among naïve HIV-infected patients in Iran J Res Med Sci. 24 31-1485
  • [9] Sigaloff KC(2018)A surveillance on protease inhibitor resistance-associated mutations among Iranian HIV-1 patients Arch Clin Infect Dis 13 6-136
  • [10] Wallis CL(2018)Prevalence of HIV-1 pre-treatment drug resistance in a southern province of Iran, 2016–2017 Arch Virol 163 57-2509